PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
6 hedge funds and large institutions have $99.3K invested in PAVmed Inc. Series Z Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
2% more capital invested
Capital invested by funds: $97K → $99.3K (+$2.32K)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$139K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$20K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$17K |
| 3 |
LCS
Levin Capital Strategies
New York
|
-$12.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJA
1
Raymond James & Associates
St Petersburg,
Florida
| $73.9K | +$139K | +335,936 | New |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $12K | -$20K | -48,193 | -47% |
|
|
LCS
3
Levin Capital Strategies
New York
| $10.3K | -$12.9K | -31,250 | -41% |
|
|
4
UBS Group
Zurich,
Switzerland
| $2.66K | +$4.28K | +10,333 | +590% |
|
5
Morgan Stanley
New York
| $220 | – | – | – |
|
6
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $220 | – | – | – |
|
|
WAM
7
Warberg Asset Management
Winnetka,
Illinois
| – | -$17K | -38,000 | Closed |
|
PAVMZ Hedge Fund Activity: Q4 2022 in Review
6 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2022, worth a combined $99.3K — up 2.4% from $97K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PAVMZ and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Raymond James & Associates, opening a new position worth an estimated $139K. The largest seller was Wolverine Asset Management, cutting an estimated $20K.
- 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2022, down from 7 in Q3 2022.
- Funds reported $99.3K of PAVmed Inc. Series Z Warrant stock for Q4 2022, up 2.4% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest PAVmed Inc. Series Z Warrant buyer in Q4 2022 was Raymond James & Associates, an estimated $139K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q4 2022 was Wolverine Asset Management, an estimated $20K sold.
Based on aggregated 13F filings for Q4 2022.